Purpose Of Review: Adult congenital heart disease (ACHD) patients have demonstrated improved survival, especially those with severely complex disease, mainly single-ventricle/Fontan physiology and those with a systemic right ventricle. We describe the heart failure phenotypes of complex CHD, reversible causes for heart failure, and considerations for advanced therapy.
Recent Findings: While initially marketed for application to patients with acquired causes for heart failure, newer devices and technologies have started to be used in the ACHD population.